Results 181 to 190 of about 482,975 (382)

Emerging anticoagulant strategies [PDF]

, 2016
James C. Fredenburgh, Peter L. Gross, Jeffrey I. Weitz   +2 more
openalex   +1 more source

Exploring the Effect of Production Conditions of Chlorella minutissima on Its Pharmaceutical Potential: A Natural Source for Bioactive Compounds

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT In this study, Chlorella minutissima UTEX 234‐1 was produced under 12.43 μmol of photons m−2 s−1 (from the side surface, I1), 23.29 μmol of photons m−2 s−1 (from the top surface, I2), and 62.14 μmol of photons m−2 s−1 (from the top surface, I3) in BG‐11 medium (B1).
Çağla Yarkent, Deniz Şenyay Öncel, Suphi S. Oncel   +2 more
wiley   +1 more source

NEW ORAL ANTICOAGULANTS: IS THAT PLAUSIBLE TO IMPLEMENT THE DATA FROM INTERNATIONAL TRIALS TO RUSSIAN POPULATION?

, 2015
S. Yu. Martsevich, A. R. Navasardian, N. A. Zakharova, М. М. Lukianov   +3 more
openalex   +2 more sources

MODERN ORAL ANTICOAGULANT TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE: INSIGHTS FROM THE CLINICAL PRACTICE [PDF]

, 2018
Otilia Țica
openalex   +1 more source

Ulvan‐Based Electrospun Nanofibres From Water Solutions: Process Conditions and Characterisations

Journal of Applied Polymer Science, EarlyView.
Ulvan‐based electrospun nanofibres. ABSTRACT Recently, marine biopolymers have attracted considerable attention due to their high biocompatibility and biodegradability, making them ideal candidates in biomedical fields such as wound care, drug delivery, and tissue engineering.
Jacopo Paini, Federica Zaccheria, Gianluca Ottolina, Claudia Vineis, Erica Savino, Alessio Varesano   +5 more
wiley   +1 more source

Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation [PDF]

, 2017
Colleen A. McHorney, Veronica Ashton, François Laliberté, Guillaume Germain, Willy Wynant, Concetta Crivera, Jeffrey Schein, Patrick Lefèbvre, Eric D. Peterson   +8 more
openalex   +1 more source

Use of Restricted Nursing and a Bovine Appeasing Substance on the Welfare, Growth Performance, and Response to Vaccination of Beef Calves at Weaning

Animal Research and One Health, EarlyView.
The effects of restricted nursing (RN) and the administration of a bovine appeasing substance (BAS) on days −8 and 0 in relation to weaning were evaluated. Both strategies were effective in improving the growth performance of beef calves. Regarding welfare, BAS ‐especially on day 0‐ was more effective than RN.
Denise E. Mussalafo, Marcelo Vedovatto, Aylpy R. D. Santos, Dalton M. Oliveira, Fabiana A. M. Sterza, Mariana Santos, Helena B. C. R. Batista, Jaíne G. Garcia, Andréa R. D. L. Souza   +8 more
wiley   +1 more source

A systematic review of patient‐reported outcomes associated with the use of direct‐acting oral anticoagulants [PDF]

, 2019
Saima Kishvar Afzal, Syed Shahzad Hasan, Zaheer Uddin Babar   +2 more
openalex   +1 more source

Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities

Arthritis &Rheumatology, EarlyView.
Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by vascular thrombosis, pregnancy morbidity, and other manifestations driven by antiphospholipid autoantibodies. In this review, we present a clinical case that illustrates some diagnostic and therapeutic challenges in managing severe, relapsing APS ...
Thalia G. Newman, Jason S. Knight
wiley   +1 more source

Direct oral anticoagulants and venous thromboembolism [PDF]

, 2016
Massimo Franchini, Pier Mannuccio Mannucci   +1 more
openalex   +1 more source